LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

EDAN Instruments Highlights Range of Lab Analyzers, ECG Devices and Ultrasound Systems

By LabMedica International staff writers
Posted on 13 Nov 2024
Print article
Image: EDAN is showcasing its latest advancements in healthcare technology at MEDICA 2024 (Photo courtesy of EDAN)
Image: EDAN is showcasing its latest advancements in healthcare technology at MEDICA 2024 (Photo courtesy of EDAN)

EDAN Instruments (Guangdong, China) is presenting its latest product innovations at MEDICA 2024 which has attracted over 83,000 attendees and 5,300 exhibitors, highlighting advancements in healthcare technology.

At this year’s MEDICA, EDAN is showcasing the i500 blood gas analyzer, one of the world's smallest benchtop analyzers with true zero maintenance, delivering over 30 parameters per test. The new Blood Sampler offers safer sampling with size options, ensuring accuracy by reducing ion interference via calcium-balanced heparin-lithium coating. EDAN is also highlighting the new H90 Series hematology analyzer which utilizes 3D fluorescence technology for precise RET, DIFF, and NRBC results. In ultrasound, EDAN is highlighting the Acclarix AX9, a portable diagnostic ultrasound system featuring the cutting-edge SynSight zone sonography platform, which has attracted widespread attention for its robust performance as a powerful solution for diverse clinical settings. Alongside the AX9, the Nano Series handheld systems being highlighted at the show offer compact and user-friendly technology to meet the demand for high-quality, portable imaging.

EDAN is also featuring its flagship F15 Series fetal and maternal monitors which are trusted for their reliability and performance. Recognized by renowned institutions worldwide, the F15 continues to evolve based on client feedback, ensuring it meets the demands of modern obstetric care with precision and confidence. The PA4 Pro biofeedback system highlighted at the show provides a portable solution for pelvic floor rehabilitation, receiving positive feedback from healthcare professionals. Additionally, EDAN is highlighting the C12 UHD colposcope which brings ultra-high-definition imaging with a 4K camera, delivering detailed visualization of lesion morphology and vascular characteristics for gynecological diagnostics.

In patient monitoring, EDAN is showcasing the upcoming iV100, a versatile solution that functions seamlessly as a multi-parameter module within the iV series, while also serving as a transport monitor and bedside monitor in one. Designed for use across diverse settings—from ambulances to hospitals—it ensures uninterrupted access to patient data, facilitating seamless, continuous, and effective care. EDAN is also showcasing the soon-to-be-released SE-1202E 12-channel ECG featuring a high-resolution screen and streamlined touch controls for easy cleaning and enhanced usability in cardiac diagnosis, alongside the new compact SE-310 ECG which brings portability and efficiency to primary care.

"Approaching its 30th anniversary, EDAN's presence this year underscores our commitment to practical, adaptable healthcare solutions for real-world challenges," said Brian He, Senior regional sales director of EDAN. "Our latest innovations are shaped by constant feedback from clinical professionals, reflecting the importance of staying connected to the frontline through events like MEDICA."

Related Links:
EDAN Instruments

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Centromere B Assay
Centromere B Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.